According to a recent SEC filing, Truveris has raised $24.7 million in financing from an undisclosed investor. Truveris seeks to bring transparency to the prescription drug ecosystem through data-driven innovations. Its platform offers customers – from individual patients to employers, retailers, pharmacy benefits stakeholders, and manufacturers